USPTO serial 79199751
VYNOVLI
Reviewed by CopyMark Law Group
Reg. 5215876Status 709
- Filing date
- Status date
- Registration date
- Jun 6, 2017
- Examiner
- COLEMAN, CIMMERIAN
- Law office
- TMEG LAW OFFICE 102
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with VYNOVLI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maury M. Tepper, III
Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRALEIGH, NC 27609UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; ] pharmaceutical preparations for use in ophthalmology [ ; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 1, 2024 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 4, 2024 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 4, 2024 | INPC | INVALIDATION PROCESSED | — |
| Aug 23, 2024 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 22, 2023 | C71T | CANCELLED SECTION 71 | — |
| Jun 6, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 30, 2018 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Oct 31, 2018 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Oct 31, 2018 | INPC | INVALIDATION PROCESSED | — |
| Oct 20, 2018 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 27, 2018 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Feb 20, 2018 | A7OK | AMENDMENT UNDER SECTION 7 - PROCESSED | — |
| Feb 20, 2018 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 28, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 7, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 7, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 6, 2017 | GPAR | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | — |
| Jul 5, 2017 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Jul 1, 2017 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 1, 2017 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 30, 2017 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jun 6, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 21, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 17, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 1, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 1, 2017 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 1, 2017 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 8, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 8, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 21, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 17, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 13, 2017 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jan 5, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |